Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puneet Opal

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Epilepsia|March 13, 2025
The cerebellum in epilepsyChristopher Elder, Rebecca Kerestes, Puneet Opal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 8, 2007
Association of spinocerebellar ataxia type 3 and spinocerebellar ataxia type 8 microsatellite expansions: genetic counseling implicationsSabrina Paganoni, Christina A Seelaus, Kelly E Ormond, et al.
The Journal of Clinical Investigation|March 14, 2018
Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1Chandrakanth Reddy Edamakanti, Jeehaeh Do, Alessandro Didonna, et al.
Neurology|May 23, 2025
Clinical Reasoning: A 57-Year-Old Man With Chronic Gait Unsteadiness and Diminished Lower Extremity SensationRadhika Rawat, Sarah Marie Brooker, Grace Elizabeth Naylor, et al.
The Journal of Biological Chemistry|January 13, 2009
Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complexRupinder K Kular, Marija Cvetanovic, Steve Siferd, et al.
Annals of Clinical and Translational Neurology|November 21, 2021
Pharmacological perturbation reveals deficits in D2 receptor responses in Thap1 null miceNatalie M Frederick, Morgan M Pooler, Parth Shah, et al.
Nature Medicine|October 18, 2011
Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1Marija Cvetanovic, Jay M Patel, Hugo H Marti, et al.
Annals of Clinical and Translational Neurology|May 21, 2021
Spinocerebellar ataxia clinical trials: opportunities and challengesSarah M Brooker, Chandrakanth Reddy Edamakanti, Sara M Akasha, et al.
Journal of the Neurological Sciences|April 9, 2021
Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy developmentMeng-Ling Chen, Chih-Chun Lin, Liana S Rosenthal, et al.
EMBO Reports|June 9, 2007
The role of LANP and ataxin 1 in E4F-mediated transcriptional repressionMarija Cvetanovic, Robert J Rooney, Jesus J Garcia, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Epilepsia|March 13, 2025
The cerebellum in epilepsyChristopher Elder, Rebecca Kerestes, Puneet Opal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 8, 2007
Association of spinocerebellar ataxia type 3 and spinocerebellar ataxia type 8 microsatellite expansions: genetic counseling implicationsSabrina Paganoni, Christina A Seelaus, Kelly E Ormond, et al.
The Journal of Clinical Investigation|March 14, 2018
Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1Chandrakanth Reddy Edamakanti, Jeehaeh Do, Alessandro Didonna, et al.
Neurology|May 23, 2025
Clinical Reasoning: A 57-Year-Old Man With Chronic Gait Unsteadiness and Diminished Lower Extremity SensationRadhika Rawat, Sarah Marie Brooker, Grace Elizabeth Naylor, et al.
The Journal of Biological Chemistry|January 13, 2009
Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complexRupinder K Kular, Marija Cvetanovic, Steve Siferd, et al.
Annals of Clinical and Translational Neurology|November 21, 2021
Pharmacological perturbation reveals deficits in D2 receptor responses in Thap1 null miceNatalie M Frederick, Morgan M Pooler, Parth Shah, et al.
Nature Medicine|October 18, 2011
Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1Marija Cvetanovic, Jay M Patel, Hugo H Marti, et al.
Annals of Clinical and Translational Neurology|May 21, 2021
Spinocerebellar ataxia clinical trials: opportunities and challengesSarah M Brooker, Chandrakanth Reddy Edamakanti, Sara M Akasha, et al.
Journal of the Neurological Sciences|April 9, 2021
Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy developmentMeng-Ling Chen, Chih-Chun Lin, Liana S Rosenthal, et al.
EMBO Reports|June 9, 2007
The role of LANP and ataxin 1 in E4F-mediated transcriptional repressionMarija Cvetanovic, Robert J Rooney, Jesus J Garcia, et al.
Pageof 7